Maha Katabi, Director, 10% Owner at Aerovate Therapeutics, Inc. (AVTE), bought 3,758,686 shares at $14.00 ($5.0M) on 2021-07-02, disclosed to the SEC on 2021-07-06.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 3,401,544 | $0 | 0.0% |
| 2 | $14.00 | 357,142 | $5.0M | 100.0% |
| Total | $1.33 avg | 3,758,686 | $5.0M | 100% |
| Filing → |
| RYZB | BUY | 2023-09-21 | $4.2M | — | Filing → |
| VERA | BUY | 2022-02-14 | $4.0M | — | Filing → |
| VERA | BUY | 2021-05-18 | $8.0M | — | Filing → |